Medicus Pharma Ltd. Common Stock (MDCX) Form 3 Medicus Pharma / Ajay Raju ownership change

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:	3235-0104
Estimated average burden
hours per response:	0.5

1. Name and Address of Reporting Person^*

Raju Ajay

(Last) (First) (Middle)

TWO LIBERTY PLACE

50 S. 16TH STREET, SUITE 2710

(Street)

PHILADELPHIA PA 19102

(City) (State) (Zip)

2. Date of Event Requiring Statement (Month/Day/Year)
12/31/2024

3. Issuer Name and Ticker or Trading Symbol
Medicus Pharma Ltd. [ MDCX ]

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

Director	X	10% Owner
Officer (give title below)		Other (specify below)

5. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

	Form filed by One Reporting Person
X	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Shares	2,000,000	I	See Footnote(1)

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

1. Name and Address of Reporting Person^*

Raju Ajay

(Last) (First) (Middle)

TWO LIBERTY PLACE

50 S. 16TH STREET, SUITE 2710

(Street)

PHILADELPHIA PA 19102

(City) (State) (Zip)

1. Name and Address of Reporting Person^*

215 Capital TOGO PHL Fund I, LP

(Last) (First) (Middle)

TWO LIBERTY PLACE

50 S. 16TH STREET, SUITE 2710

(Street)

PHILADELPHIA PA 19102

(City) (State) (Zip)

1. Name and Address of Reporting Person^*

Togo PHL Management LLC

(Last) (First) (Middle)

TWO LIBERTY PLACE

50 S. 16TH STREET, SUITE 2710

(Street)

PHILADELPHIA PA 19102

(City) (State) (Zip)

Explanation of Responses:

1. The shares are held of record by 215 Capital Togo PHL Fund I, LP ("215 Capital"). Togo PHL Management LLC (the "Management Company") has been delegated the responsibilities of the general partner of 215 Capital, Togo PHL Fund I GP, LLC, including the voting and dispositive power over the shares reported herein. Mr. Ajay Raju is responsible for managing the affairs of the Management Company including the voting and dispositive power over the shares reported herein. Mr. Raju therefore may be deemed to have voting and dispositive power over the shares reported herein.

	/s/ Ajay Raju	12/31/2024
	/s/ Ajay Raju, as Managing Member of Togo PHL Management LLC, the Management Company of 215 Capital TOGO PHL Fund I, LP	12/31/2024
	/s/ Ajay Raju, as Managing Member of Togo PHL Management LLC	12/31/2024
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.